NK cell subsets also showed lower values in SARIFA-positive patients for CD56dim CD16bright NK cell subsets (6/μL vs. 14/μL; p = 0.004) and for CD56+ CD16+ NK cells (56/μL vs. 151/μL; p < 0.001) compared to SARIFA-negative CRC patients and healthy controls. Here, NCAM1 is linked to colorectal carcinoma.